Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Benjamin Hickey Insider Profile
4 Followers
Benjamin Hickey, SVP, Chief Commerical Officer at Halozyme, holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 13.23K shares in Halozyme (Ticker: HALO), holds ― shares in Surface Oncology (Ticker: SURF).
Benjamin Hickey Halozyme (HALO)SVP, Chief Commerical Officer
Halozyme (HALO)
SVP, Chief Commerical Officer
Ranked #26,875 out of 98,743 Corporate Insiders
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
+6.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Benjamin Hickey holds in companies
Most Profitable Insider Trade
Stock:
Mirati Therapeutics
(MRTX)
(MRTX)
Rating:Informative Sell
Date:Jan 07, 2022 - Jan 07, 2023
Return:+66.10%
The most profitable trade made by Benjamin Hickey
Benjamin Hickey's Trading History
Halozyme
Oct 01, 2019
SVP, Chief Commerical Officer
Uninformative Buy
108.07K
$570.70K
Mirati Therapeutics
Jan 23, 2024
―
Uninformative Sell
―
$0.00
Surface Oncology
―
―
―
―
Mural Oncology Plc
―
Director
―
―
Bristol-Myers Squibb
―
President, RayzeBio Org
―
$39.14K
List of latest transactions for each holding click on a transaction to see Benjamin Hickey's performance on stock
You May Also Like
Benjamin Hickey insider profile FAQ
What is the percentage of profitable transactions made by Benjamin Hickey?
The percentage of profitable transactions made by Benjamin Hickey is 50%.
What is the average return per transaction made by Benjamin Hickey?
The average return per transaction made by Benjamin Hickey is 6.90%.
What stocks does Benjamin Hickey hold?
Benjamin Hickey holds: HALO, MRTX, SURF, MURA, BMY stocks.
What was Benjamin Hickey’s latest transaction?
Benjamin Hickey latest transaction was an Uninformative Sell of ―.
What was Benjamin Hickey's most profitable transaction?
Benjamin Hickey’s most profitable transaction was an Informative Sell of MRTX stock on January 7, 2022. The return on the trade was 66.10%.
What is Benjamin Hickey's role in Halozyme?
Benjamin Hickey's role in Halozyme is SVP, Chief Commerical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.